Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 4
Submit an article Journal homepage
147
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Severe Inflammatory Response in a Patient on Oral Miltefosine for Acanthamoeba Keratitis

Zhuangjun SiDepartment of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0002-6324-9183
, MDORCID Icon,
Peter B. VeldmanDepartment of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA
, MD,
James J. ReidyDepartment of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA
, MD &
Asim V. FarooqDepartment of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USACorrespondence[email protected]
, MD
Pages 1027-1028 | Received 05 Aug 2020, Accepted 17 Nov 2020, Published online: 09 Feb 2021

References

  • Dart JK, Saw VP, Sundefined K. Acanthamoeba Keratitis: diagnosis and Treatment Update 2009. Am J Ophthalmol. 2009;148(4):487–499. doi:10.1016/j.ajo.2009.06.009.
  • Polat ZA, Obwaller A, Vural A, Walochnik J. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters. Parasitol Res. 2011;110(2):515–520. doi:10.1007/s00436-011-2515-0.
  • Dorlo TPC, Balasegaram M, Beijnen JH, Vries PJD. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother. 2012;67(11):2576–2597. doi:10.1093/jac/dks275.
  • Avdagic E, Chew HF, Veldman P, et al. Resolution of Acanthamoeba keratitis with adjunctive use of oral miltefosine. Ocul Immunol Inflamm. December 2019;1–4. doi:10.1080/09273948.2019.1695853.
  • Tavassoli S, Buckle M, Tole D, Chiodini P, Darcy K. The use of miltefosine in the management of refractory Acanthamoeba keratitis. Contact Lens Anterior Eye. 2018;41(4):400–402. doi:10.1016/j.clae.2018.03.007.
  • Dewan N, Ming W, Holland SP, Yeung SN, Iovieno A. Oral miltefosine as adjunctive treatment for recalcitrant Acanthamoeba keratitis. Cornea. 2019;38(7):914–917. doi:10.1097/ico.0000000000001968.
  • Hirabayashi KE, Lin CC, Ta CN. Oral miltefosine for refractory Acanthamoeba keratitis. Am J Ophthalmol Case Rep. 2019;16:100555. doi:10.1016/j.ajoc.2019.100555.
  • Naranjo A, Martinez JD, Miller D, Tonk R, Amescua G. Systemic miltefosine as an adjunct treatment of progressive Acanthamoeba keratitis. Ocul Immunol Inflamm. May 2020;1–9. [epub ahead of print.]
  • Thulasi P, Saeed HN, Rapuano CJ, et al. Oral miltefosine as salvage therapy for refractory Acanthamoeba keratitis. Am J Ophthalmol. 2020. doi:10.1016/j.ajo.2020.09.048.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.